Advertisement
Screener

Myovant Sciences Ltd. Revenue, Remaining Performance Obligation, Amount

Myovant Sciences Ltd. Revenue, Remaining Performance Obligation, Amount

Myovant Sciences Ltd. had Revenue, Remaining Performance Obligation, Amount of $50.00 million as of 2020-03-31, per its 10-Q filed 2020-11-12.

Discontinued › Notes › Revenue from Contract with Customer

us-gaap:RevenueRemainingPerformanceObligation · last filed 2020-11-12

  • 2020-03-31: Revenue, Remaining Performance Obligation, Amount $50.00M.
  • 2020-03-30: Revenue, Remaining Performance Obligation, Amount $50.00M.
Period endRevenue, Remaining Performance Obligation, Amount
2020-03-31$50.00M
10-Q · filed 2020-11-12
2020-03-30$50.00M
10-K · filed 2020-05-18